The Gram-negative pathogen Pseudomonas aeruginosa encodes multiple protein export
systems, the substrates of which contain export signals such as N-terminal signal peptides …

Abstract The Gram-negative bacterium Pseudomonas aeruginosa represents a prototype of
multi-drug resistant opportunistic pathogens for which novel therapeutic options are urgently …

Pseudomonas aeruginosa is a Gram-negative bacterium of clinical significance. Although
the genome of PAO1, a prototype strain of P. aeruginosa, has been extensively studied …

Pseudomonas aeruginosa is a Gram‐negative bacterium that can inhabit a wide variety of
environments and infect different hosts. Human infections by this microbe are nowadays …

With the completion of many genome projects, a shift is now occurring from the acquisition of
gene sequence to understanding the role and context of gene products within the genome …

Background Drug treatments and vaccine designs against the opportunistic human
pathogen Pseudomonas aeruginosa have multiple issues, all associated with the diverse …

Abstract The Gram‐negative bacterium Pseudomonas aeruginosa is a main cause of
infection in hospitalized, burned, immunocompromised, and cystic fibrosis patients. Many …

The deluge of data generated by genome sequencing has led to an increasing reliance on
bioinformatic predictions, since the traditional experimental approach of characterizing gene …

The opportunistic pathogen Pseudomonas aeruginosa uses secretion systems to deliver
exoproteins into the environment. These exoproteins contribute to bacterial survival …

Pseudomonas aeruginosa is a major life-threatening opportunistic pathogen that commonly
infects immunocompromised patients. This bacterium owes its success as a pathogen …